Matthew Wieduwilt

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Advisory Board
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Gilead
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Kite
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Jazz
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sorrento
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes